Alda Troncone1, Riccardo Bonfanti2, Dario Iafusco3, Ivana Rabbone4, Alberto Sabbion5, Riccardo Schiaffini6, Alfonso Galderisi7, Marco Marigliano5, Novella Rapini8, Andrea Rigamonti2, Davide Tinti4, Valeria Vallone9, Angela Zanfardino3, Federico Boscari9, Simone Del Favero10, Silvia Galasso9, Giordano Lanzola11, Mirko Messori12, Federico Di Palma12, Roberto Visentin10, Roberta Calore10, Yenny Leal10, Lalo Magni12, Eleonora Losiouk11, Daniel Chernavvsky13, Silvana Quaglini11, Claudio Cobelli10, Daniela Bruttomesso9. 1. Department of Psychology, Second University of Naples, Caserta, Italy alda.troncone@unina2.it. 2. Pediatric Department and Diabetes Research Institute, Scientific Institute, Hospital San Raffaele, Milan, Italy. 3. Department of the Woman, of the Child and of the General and Specialized Surgery, Second University of Naples, Naples, Italy. 4. Department of Pediatrics, University of Turin, Turin, Italy. 5. Regional Center for Pediatric Diabetes, Pediatric Diabetes and Metabolic Disorders Unit, Azienda Ospedialiera Universitaria Integrata of Verona, Verona, Italy. 6. Unit of Endocrinology and Diabetes, Bambino Gesù, Children's Hospital, Rome, Italy. 7. Department of Woman's and Child's Health, University of Padua, Padua, Italy. 8. Pediatric Diabetology Unit, Policlinico di Tor Vergata, University of Rome Tor Vergata, Rome, Italy. 9. Unit of Metabolic Diseases, Department of Internal Medicine, University of Padova, Padova, Italy. 10. Department of Information Engineering, University of Padova, Padova, Italy. 11. Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy. 12. Department of Civil Engineering and Architecture, University of Pavia, Pavia, Italy. 13. Center for Diabetes Technology, University of Virginia, Charlottesville, VA.
Abstract
OBJECTIVE: To explore the experiences of children with type 1 diabetes and their parents taking part in an artificial pancreas (AP) clinical trial during a 7-day summer camp. RESEARCH DESIGN AND METHODS: A semistructured interview, composed of 14 questions based on the Technology Acceptance Model, was conducted at the end of the clinical trial. Participants also completed the Diabetes Treatment Satisfaction Questionnaire (DTSQ, parent version) and the AP Acceptance Questionnaire. RESULTS: Thirty children, aged 5-9 years, and their parents completed the study. A content analysis of the interviews showed that parents were focused on understanding the mechanisms, risks, and benefits of the new device, whereas the children were focused on the novelty of the new system. The parents' main concerns about adopting the new system seemed related to the quality of glucose control. The mean scores of DTSQ subscales indicated general parents' satisfaction (44.24 ± 5.99, range 32-53) and trustful views of diabetes control provided by the new system (7.8 ± 2.2, range 3-12). The AP Acceptance Questionnaire revealed that most parents considered the AP easy to use (70.5%), intended to use it long term (94.0%), and felt that it was apt to improve glucose control (67.0%). CONCLUSIONS: Participants manifested a positive attitude toward the AP. Further studies are required to explore participants' perceptions early in the AP development to individualize the new treatment as much as possible, and to tailor it to respond to their needs and values.
OBJECTIVE: To explore the experiences of children with type 1 diabetes and their parents taking part in an artificial pancreas (AP) clinical trial during a 7-day summer camp. RESEARCH DESIGN AND METHODS: A semistructured interview, composed of 14 questions based on the Technology Acceptance Model, was conducted at the end of the clinical trial. Participants also completed the Diabetes Treatment Satisfaction Questionnaire (DTSQ, parent version) and the AP Acceptance Questionnaire. RESULTS: Thirty children, aged 5-9 years, and their parents completed the study. A content analysis of the interviews showed that parents were focused on understanding the mechanisms, risks, and benefits of the new device, whereas the children were focused on the novelty of the new system. The parents' main concerns about adopting the new system seemed related to the quality of glucose control. The mean scores of DTSQ subscales indicated general parents' satisfaction (44.24 ± 5.99, range 32-53) and trustful views of diabetes control provided by the new system (7.8 ± 2.2, range 3-12). The AP Acceptance Questionnaire revealed that most parents considered the AP easy to use (70.5%), intended to use it long term (94.0%), and felt that it was apt to improve glucose control (67.0%). CONCLUSIONS:Participants manifested a positive attitude toward the AP. Further studies are required to explore participants' perceptions early in the AP development to individualize the new treatment as much as possible, and to tailor it to respond to their needs and values.
Authors: Gregory P Forlenza; Dan Raghinaru; Faye Cameron; B Wayne Bequette; H Peter Chase; R Paul Wadwa; David M Maahs; Emily Jost; Trang T Ly; Darrell M Wilson; Lisa Norlander; Laya Ekhlaspour; Hyojin Min; Paula Clinton; Nelly Njeru; John W Lum; Craig Kollman; Roy W Beck; Bruce A Buckingham Journal: Pediatr Diabetes Date: 2017-11-20 Impact factor: 4.866
Authors: J Lawton; M Blackburn; D Rankin; J Allen; F Campbell; L Leelarathna; M Tauschmann; H Thabit; M E Wilinska; R Hovorka Journal: Diabet Med Date: 2019-01-29 Impact factor: 4.359
Authors: Julia Lawton; Maxine Blackburn; David Rankin; Janet M Allen; Fiona M Campbell; Lalantha Leelarathna; Martin Tauschmann; Hood Thabit; Malgorzata E Wilinska; Daniela Elleri; Roman Hovorka Journal: Diabetes Technol Ther Date: 2019-02-05 Impact factor: 6.118
Authors: Gianluca Musolino; Klemen Dovc; Charlotte K Boughton; Martin Tauschmann; Janet M Allen; Katrin Nagl; Maria Fritsch; James Yong; Emily Metcalfe; Dominique Schaeffer; Muriel Fichelle; Ulrike Schierloh; Alena G Thiele; Daniela Abt; Harald Kojzar; Julia K Mader; Sonja Slegtenhorst; Nicole Ashcroft; Malgorzata E Wilinska; Judy Sibayan; Nathan Cohen; Craig Kollman; Sabine E Hofer; Elke Fröhlich-Reiterer; Thomas M Kapellen; Carlo L Acerini; Carine de Beaufort; Fiona Campbell; Birgit Rami-Merhar; Roman Hovorka Journal: Pediatr Diabetes Date: 2019-06-13 Impact factor: 4.866